Skip to main navigation
Great Science. Great Medicine
ChemoCentryx
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Partnering
    • Contact Us
  • Pipeline
    • Overview
    • Orphan and Rare Diseases
    • Chronic Kidney Disease
    • Immuno-Oncology and Other Therapeutic Areas
      • Preclinical Candidates
    • Other Inflammatory and Autoimmune Diseases
      • Vercirnon
      • CCX507
      • Th17 Driven Diseases and CCR6
  • Diseases
    • Orphan and Rare Diseases
    • Chronic Kidney Disease
    • Immuno-oncology
    • Other Inflammatory and Autoimmune Diseases
  • Science
  • Investors
    • Overview
    • News Releases
    • Events & Presentations
    • Financials & Filings
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Analyst Coverage
    • Corporate Governance
      • Management Team
      • Board of Directors
      • Committee Composition
    • Investor FAQs
    • Contact Us
  • Careers
    • Culture
    • Benefits
    • Job Postings
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Partnering
    • Contact Us
  • Pipeline
    • Overview
    • Orphan and Rare Diseases
    • Chronic Kidney Disease
    • Immuno-Oncology and Other Therapeutic Areas
      • Preclinical Candidates
    • Other Inflammatory and Autoimmune Diseases
      • Vercirnon
      • CCX507
      • Th17 Driven Diseases and CCR6
  • Diseases
    • Orphan and Rare Diseases
    • Chronic Kidney Disease
    • Immuno-oncology
    • Other Inflammatory and Autoimmune Diseases
  • Science
  • Investors
    • Overview
    • News Releases
    • Events & Presentations
    • Financials & Filings
      • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Investment Calculator
      • Analyst Coverage
    • Corporate Governance
      • Management Team
      • Board of Directors
      • Committee Composition
    • Investor FAQs
    • Contact Us
  • Careers
    • Culture
    • Benefits
    • Job Postings
ChemoCentryx
  • Company
    • Overview
    • Management Team
    • Board of Directors
    • Advisory Board
    • Strategic Partners
    • In the Community
    • Contact
  • Pipeline
  • Diseases
    • Chronic Kidney Disease
    • Orphan and Rare Diseases
    • Other Inflammatory and Autoimmune Diseases
    • Immuno-oncology
  • Science
    • Overview
    • Complement System and Rare Diseases
    • Chemokines and Inflammation/Autoimmune Disorders
    • Chemokines and Immuno-oncology
  • Investors
    • Overview
    • News Releases
    • Events & Presentations
    • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Analyst Coverage
    • Corporate Governance
      • Leadership Team
      • Board of Directors
      • Committee Composition
    • Investor FAQs
    • Contact Us
  • Careers
    • Culture
    • Job Postings
    • Benefits
Go to...
  • Company
    • Overview
    • Management Team
    • Board of Directors
    • Advisory Board
    • Strategic Partners
    • In the Community
    • Contact
  • Pipeline
  • Diseases
    • Chronic Kidney Disease
    • Orphan and Rare Diseases
    • Other Inflammatory and Autoimmune Diseases
    • Immuno-oncology
  • Science
    • Overview
    • Complement System and Rare Diseases
    • Chemokines and Inflammation/Autoimmune Disorders
    • Chemokines and Immuno-oncology
  • Investors
    • Overview
    • News Releases
    • Events & Presentations
    • SEC Filings
    • Stock Information
      • Historic Stock Lookup
      • Analyst Coverage
    • Corporate Governance
      • Leadership Team
      • Board of Directors
      • Committee Composition
    • Investor FAQs
    • Contact Us
  • Careers
    • Culture
    • Job Postings
    • Benefits

Investors

Financials & Filings

Annual Reports

Title Documents

2019 Annual Report

  • Add Files
    2019 Annual Report 12.7 MB

Proxy Statements

Filing date View
04/06/20
0001193125-20-099508.pdf
0001193125-20-099508.rtf
0001193125-20-099508.xls
View HTML
04/08/19
0001193125-19-100682.pdf
0001193125-19-100682.rtf
0001193125-19-100682.xls
View HTML

Form 10-K

Filing date View
03/10/20 View HTML
0001564590-20-009787.pdf
0001564590-20-009787.rtf
0001564590-20-009787.xls
EX-101.INS - XBRL INSTANCE DOCUMENT
03/11/19 View HTML
0001193125-19-070954.pdf
0001193125-19-070954.rtf
0001193125-19-070954.xls
EX-101.INS - XBRL INSTANCE DOCUMENT

Form 10-Q

Filing date View
11/09/20
0001564590-20-052521.pdf
0001564590-20-052521.rtf
0001564590-20-052521.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
08/10/20
0001564590-20-038951.pdf
0001564590-20-038951.rtf
0001564590-20-038951.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Investor Relations

  • Overview
  • News Releases
  • Events & Presentations
  • Financials & Filings
    • SEC Filings
  • Stock Information
    • Historic Stock Lookup
    • Investment Calculator
    • Analyst Coverage
  • Corporate Governance
    • Management Team
    • Board of Directors
    • Committee Composition
  • Investor FAQs
  • Contact Us

Shareholder Tools

  • Printed Materials
  • Email Alerts Subscription
  • Snapshot
  • Print
  • Share
  • Facebook
  • LinkedIn
  • Twitter
  • RSS

COMPANY

  • Overview
  • Management Team
  • Board of Directors
  • Contact Us

PIPELINE

  • Overview
  • Orphan and Rare Diseases
  • Chronic Kidney Disease
  • Immuno-Oncology and Other Therapeutic Areas
  • Other Inflammatory and Autoimmune Diseases

Diseases

  • Orphan and Rare Diseases
  • Chronic Kidney Disease
  • Immuno-Oncology
  • Other Inflammatory and Autoimmune Diseases

SCIENCE

INVESTORS

Careers

  • Culture
  • Benefits
  • Job Postings

CONTACT INFORMATION

850 Maude Avenue
Mountain View, CA 94043

Phone: +1.650.210.2900

Fax: +1.650.210.2910

Email: info@chemocentryx.com

© 2021 ChemoCentryx, Inc. | Legal and Privacy